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Abstract 
A protein extracted from a urate - calcium oxalate 
stone by electrodialysis is also excreted in the urine 
which served as the source material for its purification 
by FPLC after separation on an ACA44 column. It has 
an amino acid composition appropriate for a cationic 
protein. One peptide obtained by cyanogen bromide 
cleavage has significant (approximately 60 % ) homology 
with CD59 protein (protectin). Both proteins have wide 
distribution, the unknown having been found in bile, 
cholesterol gallstones, and the wall of the aorta. 
However, the two proteins appear to be immunologically 
different. 
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Introduction 
Many proteins have been identified in renal stones 
since the pioneering work of Boyce et al. [2]. Some, 
like albumin and transferrin, are components of serum 
and urine, some are present in urine but absent or barely 
detectable in serum such as the Tamm Horsfall [3] pro-
tein and nephrocalcin [5], others have been extracted but 
not characterized and remain to be identified. This last 
group of proteins may be of special interest for their 
likely selective incorporation into stones would suggest 
an important role in the early events of stone formation. 
In order to study these early events in vitro, it is neces-
sary to isolate and purify these proteins with minimal al-
teration of their native state. In this paper we report the 
purification and characterization of such a protein origi-
nally extracted from a urate-calcium oxalate renal stone 
and subsequently from urine. 
Materials and Methods 
This urate-calcium oxalate stone, the original 
source of the protein, was extracted as previously de-
scribed by electrodialysis [l] in the ISCO apparatus and 
part of the extract served to develop an antiserum in the 
rabbit. This antiserum was used to scan concentrated 
urine and other extracts by immunodiffusion in agar. A 
urinary protein with reaction of identity with one of the 
stone proteins was detected, thus providing an unlimited 
quantity of material to isolate and purify the protein as 
follows: the urine is concentrated by dialysis against 
polyethylene glycol [PEG] and the proteins are precipi-
tated by a finer PEG [molecular weight (M.W.) = 3,500 
Dal tons (D)] at a final concentration of 20%. The PEG 
is separated from the protein solution by the addition of 
1 M sodium sulfate [4] and the lower phase is carefully 
removed and dialyzed in the cold room against large vol-
umes of reverse osmosis distilled water for a minimum 
of 24 hours. The specimen is then concentrated against 
PEG and centrifuged in a refrigerated centrifuge. It is 
applied to a column (AcA44-Ultrogel-IBF, 10-130 kD 
M.W.) and the protein fractions eluted with 0.09 M 
Tris-Glycine buffer pH 8.2 at 4 °C. The void volume is 
measured and the eluate is divided into three fractions 
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Figure la (above). SDS-PAGE electrophoresis. a and b represent 30 µl aliquots 
of the purified protein; c = 50 µI. The concentration of the specimen is 2 mg/ml. 
The stain is Coomassie. 
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Figure lb (at right). Molecular weight standard from 20-92 kD; the 
concentration of unknown is 3-4 mg/ml and the quantity 40 µI. The stain is 
Coomassie. 1.4 
Fig. 2a \ 
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Figure 3 (above). Immuno-dot of the purified protein. 
a, b and c represent an 0.1 µl aliquot applied 5, 3 and 2 
times, respectively, to pure nitrocellulose with a Hamil-
ton syringe. The nitrocellulose is thoroughly dried be-
tween each application. The stain is purple on a white 
background. The color developing reagent contains 5-
bromo-4-chloro-indolyl phosphate (BCIP) and nitroblue 
tetrazolium (NBT). Total concentration = 2 mg/ml; a 
= 0.5 µI; b = 0.3 µl; c = 0.2 µI. 
Fig. 2b 10 
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Figure 2a (at left). Isoelectric focusing. Lanes l and 
6 represent the purified protein which has an isoelectric 
point of 8.4; lanes 2 and 3 represent gallbladder stone 
extracts; 4 and 5 kidney stone extracts, and 7 is the 
standard on the far right with isoelectric point of 3 to 
10. The samples are 5 µ1; the standard 1 µI. The sam-
ple concentration is approximately 2 mg/ml; the standard 
concentration = 0.01 mglµl. 
Figure 2b (above). Isoelectric focusing. One µl of 
standard ph 3-10 on right. Five µI aliquots of purified 
protein on left (concentration 2 mg/ml). Arrow = 8.4. 
Isolation and purification of a shared protein 
Table 1. Percentage composition of 
amino acids of cationic protein. 























and the values read on a spectrophotometer at 280 nm. 
Fraction II is pooled and dialyzed against large volumes 
of distilled water in the cold room, followed by concen-
tration against PEG to a volume of 5-10 ml. The con-
centrated fraction is mixed with a small volume of SI-17 
(Pharmacia LKB, Piscataway, NJ) in 0.09 M Tris-Gly-
cine buffer, allowed to stand for at least 2 hours and 
centrifuged for removal of any pigment present. After 
ultracentrifugation, the protein containing peak is 
chromatographed by fast protein liquid chromatography 
(FPLC) on a polyanion SI-17 column (Pharmacia LKB). 
Solution A is tris-glycine and solution B is tris-glycine 
sodium chloride. The protein is eluted in the first peak 
which is concentrated and dialyzed against distilled de-
ionized water. The purity is checked by immunodiffu-
sion, SDS polyacrylamide gel electrophoresis (SDS-
PAGE) and immunoblotting. 
The molecular weight was estimated by SDS-
PAGE (Figures la and lb) and gel filtration (calibration 
kit; Pharmacia LKB); and the isoelectric point (Figure 
2) was determined on agarose bound to a rigid support 
(FMC Bioproducts, Rockland, ME). Amino acid analy-
sis (Table 1) and amino acid sequencing (see Results), 
immunodotting (Figure 3) and immunodiffusion were 
also performed. An Amplified Alkaline Phosphatase 
Goat Anti-Rabbit Immuno Assay Kit (Bio-Rad, Chemical 
Div., Richmond, CA) was used to assay the purified 
protein and an Immuno-Blot Alkaline Phosphatase (Goat 
Anti-Mouse, Bio-Rad) was employed to assay CD59 
(monoclonal antibody, procured from Accurate Chemical 
and Scientific Corporation, Westbury, NY). The N-
terminal amino acid sequence was performed on a pep-
tide generated by digestion of the protein with cyanogen 
bromide and after separation of the peptides on a Vydac 
Reverse Phase C 18 column (4.6 mm x 25 cm) (the anal-
ysis was carried out by O/T Biotechnology Research 
Institute, Rockville, MD). 
Results 
Scanning with the antiserum to proteins of the 
urate-calcium oxalate stone revealed the presence of the 
protein in bile, cholesterol gallstones and extracts from 
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the aorta. The molecular weight of approximately 82 kD 
on SDS PAGE is consistent with the result obtained on 
AcA44 gel filtration, and the isoelectric point of 8.4, 
classifying the protein as cationic, is compatible with the 
high content of basic amino acids. 
Partial sequencing of a peptide obtained after 
cyanogen bromide cleavage of the protein necessitated 
by a blocked N-terminal revealed approximately 60% 
homology with CD59 (Protectin). Immunodotting and 
immunodiffusion with the CD59 monoclonal antibody 
failed to detect the purified protein. 
The sequence of the peptide generated from the 








The constant identity of the two proteins, one 
extracted from stone and the other purified from urine, 
as displayed by electrophoretic mobility and immunolog-
ical activity, suggests that the procedure of extraction 
preserves the native state of the protein. This would 
give more credence to the in vitro studies of the role of 
this and other similarly extracted proteins in the forma-
tion of urinary tract stones. 
The cationic charge of the protein may be respon-
sible for its presence in the stone through its linkage 
with the anionic proteins, and once combined, could 
form the elementary matrix ready to receive its first 
cargo of salts if such are available in a supersaturated 
solution. 
The selective incorporation of the protein into 
stones and its distribution in calcification prone sites 
suggest a role for this protein in the process. 
The partial homology with CD59 (Protectin) 
would enlarge the distribution and role of an isoform of 
this protein while the failure to react with a monoclonal 
antibody to CD59 leaves the new protein without identi-
fication. Further research on the nature and role of this 
interesting protein is being pursued. 
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Discussion with Reviewers 
M.I. Resnick: Do the authors believe that the protein 
is similar to proteins found in other stones such as pure 
calcium oxalate struvite? What role will proteins play in 
stones of this composition? 
Authors: Yes, we believe that the protein is similar to 
proteins found in other stones such as pure calcium 
oxalate struvite. The role of the protein is speculative 
at the present time. It is being studied, in vitro, by 
physical chemical techniques. 
